Flow cytometric mast cell-mediated cytotoxicity assay: A three-color flow cytometric approach using monoclonal antibody staining with annexin V/propidium iodide co-labeling to assess human mast cell-mediated cytotoxicity by fluorosphere-adjusted counts

Journal of Immunological Methods

Volumn 365, Issue 1-2, 2011, Pages 166-173

  Ozdemir, Oner ^a  

^a GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Annexin V; Apoptosis; Cell mediated cytotoxicity; Daudi; Flow cytometry; Fluorosphere adjusted counts; Mast cell; Monoclonal antibody; Necrosis; Propidium iodide; Raji

Indexed keywords

LIPOCORTIN 5; METHYLCELLULOSE; MONOCLONAL ANTIBODY; PROPIDIUM IODIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL INTERACTION; CELL LOSS; CELL MEDIATED CYTOTOXICITY; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DAUDI CELL; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MAST CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; RAJI CELL; STAINING; TARGET CELL; TUMOR; TUMOR CELL;

ANNEXIN A5; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CHROMIUM RADIOISOTOPES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; MAST CELLS; NEOPLASMS; PROPIDIUM; STAINING AND LABELING;

EID: 79551584964     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.12.015     Document Type: Article

References (31)

1. Aromando R.F., Pérez M.A., Heber E.M., et al. Potential role of mast cells in hamster cheek pouch carcinogenesis. Oral Oncol 2008, 44:1080-1087.
2. Benyon R.C., Bissonnette E.Y., Befus A.D. Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies. J Immunol 1991, 147:2253-2258.
3. Bissonnette E.Y., Hogaboam C.M., Wallace J.L., Befus A.D. Potentiation of tumor necrosis factor alpha-mediated cytotoxicity of mast cells by their production of nitric oxide. J Immunol 1991, 147:3060-3065.
4. Büyükavci M., Özdemir Ö., Buck S., Stout M., Ravindranath Y., Savaşan S. Melatonin cytotoxicity in human leukemia cells: Relation with its pro-oxidant effect. Fundam Clin Pharmacol 2006, 20:73-79.
5. Clarke G.R., Shirzadeh H., Pang G., Beagley K.W., Burton R.C., Smart Y.C. TNF-alpha is not the sole mediator of WEHI-164 tumour cell killing in natural cytotoxicity. Cytokine 1997, 9:254-262.
6. Della Rovere F., Granata A., Monaco M., Basile G. Phagocytosis of cancer cells by mast cells in breast cancer. Anticancer Res 2009, 29:3157-3161.
7. Derby E., Reddy V., Kopp W., et al. Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity. Immunol Letters 2001, 78:35-39.
8. Goldberg J.E., Sherwood S.W., Clayberger C. A novel method for measuring CTL and NK cell mediated cytotoxicity using annexinV and two-color flow cytometry. J Immunol Methods 1999, 224:1-9.
9. Hara M., Matsumori A., Ono K., et al. Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. Circulation 1999, 100:1443-1449.
10. Kataoka T.R., Morii E., Oboki K., Kitamura Y. Strain-dependent inhibitory effect of mutant mi-MITF on cytotoxic activities of cultured mast cells and natural killer cells of mice. Lab Invest 2004, 84:376-384.
11. King M.A. Detection of dead cells and measurement of cell killing by flow cytometry. J Immunol Methods 2000, 243:155-166.
12. Latti S., Leskinen M., Shiota N., Wang Y., Kovanen P.T., Lindstedt K.A. Mast cell-mediated apoptosis of endothelial cells in vitro: A paracrine mechanism involving TNF-alpha-mediated down- regulation of bcl-2 expression. J Cell Physiol 2003, 195:130-138.
13. Özdemir Ö. Immunosurveillance function of human mast cell?. World J Gastro 2005, 11:7054-7056.
14. Özdemir Ö. Human mast cell cytotoxicity against human lymphoma and myeloid leukemia cells. J Allergy Clin Immunol 2006, 117:S17. (abstract).
15. Özdemir Ö. Mast cells and the tumor-associated neoangiogenesis. Med Sci Monit 2006, 12:LE 9-LE 11.
16. Özdemir Ö. Mast cell density, angiogenesis and their significance in tumor development. Gynecol Oncol 2006, 100:628-629.
17. Özdemir Ö. Can chymase-positive mast cells play a role in the progression of gastric cancer via angiogenesis?. J Surg Oncol 2006, 94:260-262.
18. Özdemir Ö. Can a mast cell subtype (MC(T)) play a role in the progression of endometrial cancer through angiogenesis?. Am J Obstet Gynecol 2006, 195:e24.
19. Özdemir Ö. Evaluation of human mast cell-mediated cytotoxicity by DIOC18 target cell labeling in flow cytometry. J Immunol Methods 2007, 319:98-103.
20. Özdemir Ö. Flow cytometric cell-mediated cytotoxicity assay. J Immunol Methods 2007, 318:158-159.
21. Özdemir Ö., Savaşan S. Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine activated killer cell cytotoxicity against human leukemia/lymphoma cells. Clin Immunol 2005, 115:240-249.
22. Özdemir Ö., Savaşan S. Short and long-term mast cell mediated cytotoxicity against NK/LAK-sensitive and -resistant cells. PAS 2005, 57:1531. (abstract).
23. Özdemir Ö., Ravindranath Y., Savaşan S. Evaluation of long-term liquid culture grown human bone marrow mast cell cytotoxicity against human leukemia cells. Blood 2002, 100:45b. (abstract).
24. Özdemir Ö., Ravindranath Y., Savaşan S. Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinv/propidium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometry. Cytom A 2003, 56A:53-60.
25. Özdemir Ö., Moore C., Ravindranath Y., Savaşan S. Can mast cells mediate natural cytotoxicity in short term culture?. Ann Allergy Asthma Immunol 2004, 94:185. (abstract).
26. Özdemir Ö., Ravindranath Y., Savaşan S. Mechanisms of superior anti-tumor cytotoxic response of Interleukin-15-induced lymphokine-activated killer cells. J Immunother 2005, 28:44-52.
27. Savaşan S., Buck S., Özdemir Ö., et al. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia. Leuk Lymphoma 2005, 46:833-840.
28. Sinnamon M.J., Carter K.J., Sims L.P., Lafleur B., Fingleton B., Matrisian L.M. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 2008, 29:880-886.
29. Wasiuk A., de Vries V.C., Hartmann K., Roers A., Noelle R.J. Mast cells as regulators of adaptive immunity to tumours. Clin Exp Immunol 2009, 155:140-146.
30. Xiang M., Gu Y., Zhao F., Lu H., Chen S., Yin L. Mast cell tryptase promotes breast cancer migration and invasion. Oncol Rep 2010, 23:615-619.
31. Zamai L., Maeiani A.R., Zauli G., et al. Kinetics of in vitro natural killer activity against K-562 cells as detected by flow cytometry. Cytometry 1998, 32:280-285.